Oculis Holding (OCS) Fireside Chat August 13, 2025 11:00 AM ET Speaker0Good morning, and thank you for joining the HC Wainwright fifth Annual Ophthalmology Virtual Conference. For this session, we have a panel discussion, and I'd like to welcome the following panelists to share with us their view on multiple drug candidates currently in pivotal stage of clinical development for retinal disorders. Doctor Hendrik Shaw, chief medical officer of Eliot Bio. Doctor Snehao Shah, president of r and d at Oculus Hold ...